Bortezomib in multiple myeloma

Matt Stenger, Vincent Rajkumar

Research output: Contribution to journalShort surveypeer-review


This novel proteasome inhibitor appears to improve response rates and survival in patients with progressive multiple myeloma.

Original languageEnglish (US)
Pages (from-to)77+82
JournalCommunity Oncology
Issue number2
StatePublished - 2004

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Bortezomib in multiple myeloma'. Together they form a unique fingerprint.

Cite this